Frank Richard
Ingelheim Am Rhein, RP, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Safety and pharmacodynamics of the ferroportin inhibitor vamifeport in patients with non-transfusion-dependent β-thalassemia: results from a randomized phase 2a study.
Journal: Orphanet journal of rare diseases
Published: April 03, 2025
Bayesian Strategies in Rare Diseases.
Journal: Therapeutic innovation & regulatory science
Published: September 28, 2022
Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development.
Journal: Expert review of hematology
Published: July 29, 2021
Use, Persistence, Efficacy, and Safety of Apixaban in Patients with Non-Valvular Atrial Fibrillation in Unselected Patients in Germany. Results of the Prospective Apixaban in Atrial Fibrillation (APAF) Registry.
Journal: Cardiology and therapy
Published: April 27, 2020
Oral ferroportin inhibitor VIT-2763: First-in-human, phase 1 study in healthy volunteers.
Journal: American journal of hematology
Published: October 18, 2019
Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 Trial.
Journal: Clinical pharmacology in drug development
Published: September 25, 2018
A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD.
Journal: International journal of chronic obstructive pulmonary disease
Published: March 26, 2016
Effect of tiotropium on COPD exacerbations: A systematic review.
Journal: Respiratory medicine
Published: September 02, 2015
Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma.
Journal: The Journal of allergy and clinical immunology
Published: May 08, 2015
Bioequivalence evaluation of a folate-supplemented oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium versus ethinylestradiol/drospirenone and levomefolate calcium alone.
Journal: Clinical drug investigation
Published: August 23, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026